Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
North Atlantic Smaller Companies Investment Trust Plc LSE:NAS London Ordinary Share GB0006439003 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -40.00 -1.38% 2,850.00 2,840.00 2,860.00 2,840.00 2,810.00 2,840.00 10,348 16:35:14
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments 12.3 5.9 41.2 69.1 411

North Atlantic Smaller C... Share Discussion Threads

Showing 251 to 273 of 275 messages
Chat Pages: 11  10  9  8  7  6  5  4  3  2  1
DateSubjectAuthorDiscuss
07/10/2020
12:29
They had £44m of treasuries at interim mark. Spent £392K yesterday so if they spent them all they could in theory keep this up for 100 days at current prices. I doubt they'd spend that much but volume is not much more than 14,000 shares a day so it would probably help a lot to close the discount to NAV. They are floating off some of their biotech investments too so that should help NAV a fair bit.
loglorry1
07/10/2020
11:35
They must have heard you SpectoAcc! Buying their own shares at last.
chinahere
17/9/2020
08:21
Just very cautious. I think there's better than 50/50 chance of revisting the lows over the next year and cash will come in handy even if eroded by 4-5% real inflation in the meantime. Interested to see Mills moves from this point on.
p1nkfish
17/9/2020
07:04
They've had those US Treasuries forever - slightly fewer than before, but still. If they don't spend the money now, when will they? (Surely there's a case for buybacks at a c.30% discount to NAV, rather than earning "..Almost nothing.." on T Bills?).
spectoacc
17/9/2020
06:20
No way to know, a very cryptic mention and a bit of a tease. I think NAS is raising whatever cash it can via taking advantage now ready for something. Perhaps an anticipated big turn down or changes to landscape post Brexit. Some bargains will be thrown up.
p1nkfish
16/9/2020
21:59
the other possibility to list mentioned - is that likely to be the holding company for interactive investor?
mw8156
16/9/2020
21:38
yes, excellent news. Definitely the right time to list the healthcare companies. Opportunistic as ever!
topvest
16/9/2020
21:00
SBS due to see a public offering in Sept 2020, return to market.
p1nkfish
16/9/2020
21:00
SBS due to see a public offering in Sept 2020, return to market.
p1nkfish
16/9/2020
20:49
Interims out: chief executive's review During the six month period under review the fully diluted net asset value fell by 9.7% (with Oryx under the equity method of accounting) as compared to a rise in the Sterling adjusted Standard & Poors Composite Index of 2.4%. The performance however compares very favourably with appropriate UK indices. The Company incurred a loss for the period of GBP629,000 (31 July 2019: profit of GBP3,671,000) as dividends were slashed in the UK and interest income on US Treasuries fell to almost nothing. The Company did not purchase any ordinary shares for cancellation during the period. quoted portfolio The COVID pandemic materially impacted a significant part of the quoted portfolio which resulted in some of our businesses such as Gleeson and Ten Entertainment closing entirely for a period. Stobart was also very hard hit as its principal asset Southend Airport ground to a standstill. Whilst these businesses are now once again operating, it most likely will take a long time before they return to normality and their share prices return to former levels. Against that, it was fortunate that the portfolio has some exposure to life sciences with EKF, Renalytix and Ergomed (which has now been sold) all performing well. Finally, Oryx very significantly outperformed its benchmark again and Odyssian also outperformed, although to a much lesser extent. US portfolio The US portfolio, albeit small, materially underperformed the S&P due to its heavy exposure to banks. unquoted portfolio The investment in Jaguar Holdings a provider of airline catering services had to be written down, although it is pleasing to note that the group remained cash flow positive throughout the period. Sherwood Holdings (Source Bioscience) however benefitted from COVID testing and was written up in anticipation of a public offering which is expected to occur in September. It is also expected that Verici DX will be listed in September with very strong demand already in place from institutions. Finally, there is a possibility that another of the unquoted investments will go public at a very substantial premium to the July valuation although, if this happens, it will be towards the end of the year. Outlook Stock markets, and in particular the United States, have performed extraordinarily well given the damage done to public finances and the economy. As worldwide schemes to protect employment are unwound and unemployment rises, it is hard to be overly optimistic about corporate profits in most industries. We do, however, expect a modest level of corporate activity which might give some underpinning to equities. We did however take the opportunity of the weakness in the market to build new positions in Circassia and Tribal Group, both of which based on end August share prices have performed well since purchase. Finally, Assetco was largely successful in contesting Grant Thornton's appeal so hopefully the Company will receive a substantial cash injection as the lawsuit reaches conclusion and the company returns cash to investors. C H B Mills
rambutan2
28/7/2020
11:54
The Board announces that as at 30 June 2020 the unaudited net asset value per share (excluding current period revenue) under the equity accounting method was 4,108.60p.
davebowler
26/6/2020
13:43
30% discount to NAV.
davebowler
26/6/2020
13:42
The Board announces that as at 31 May 2020 the unaudited net asset value per share (excluding current period revenue) under the equity accounting method was 4,050.05p.
davebowler
02/6/2020
14:02
Cracking first name for our Director mentioned in the RNS. Jay, Robin or even Phoenix doesn't come close to Peregrine!
davebowler
28/5/2020
11:04
Discount to this NAV is now 27% ! The Board announces that as at 30 April 2020 the unaudited net asset value per share (excluding current period revenue) under the equity accounting method was 3,836.28p.
davebowler
14/5/2020
16:55
hTTps://www.stockomendation.com/rns/27680133
davebowler
14/5/2020
07:40
Thanks @p1nkfish. Not forgetting Trump's bleach approach! Anti-malarial been debunked I thought, & above is only Phase II. Remdesivir still the big hope IMO, tho not without some serious side effects.
spectoacc
14/5/2020
07:35
Various inc vitamin D, anti-malarial and below. Either bolster against (supposedly) or alleviate, not cure. Https://www.healtheuropa.eu/drug-combination-shows-promise-for-treating-covid-19/99874/
p1nkfish
14/5/2020
07:17
Those T Bills were a great buy & am glad to see them being sold again to invest lower. But found this statement curious: "Even if effective vaccines take time to develop, the clarification that there are a number of potential treatments will help to alleviate public alarm during the mitigation phase." Am aware of Remdesivir, which the jury is still out on, but not anything else "clarified" as a treatment? Quite a statement to make - and to base investment decisions on.
spectoacc
14/5/2020
07:06
I'd rather shelter here than in many other places. Mills has been actively adding to or opening positions recently so sees value in a few areas.
p1nkfish
14/5/2020
04:11
Prelims released tues: ...Our cash holdings (comprising cash at banks and US treasury bills) fell significantly during the period from approximately GBP122m to GBP82m. This is due to the repurchase of company shares for redemption and a number of new investments which we believe trade at significant discount to fair value. Since the end of the period all world markets have fallen very substantially due to the onset of the COVID-19 virus which has disastrously impacted economic activity. Many of our businesses have either had to shut down or have had operations substantially curtailed. As noted above we have entered this downturn with very substantial liquid resources. Shareholders will already be aware we have tended to invest mainly in companies with strong balance sheets. We are therefore very well placed to support our businesses where appropriate. To date we have helped refinance Ten Entertainment so that it can now withstand a shutdown of fifteen months at a cost of less than GBP1m. We would expect that no more than two or three other investments will require funding with an estimated cost to the Company of no more than GBP5m. Either I or a member of my team have now spoken to every major investment in the Company and Oryx (which also has comparable cash balances) and can confirm that we are confident that our business will survive this very difficult economic downturn. It is however inevitable that corporate activity will be curtailed for some time so that realisations may take longer to occur than was originally anticipated. Notwithstanding this I anticipate that the next few months will present some good opportunities and therefore remain confident that the Company will continue to provide positive returns once a degree of normality is restored. Christopher Mills Chief Executive & Investment Manager 12 May 2020 https://uk.advfn.com/stock-market/london/north-atlantic-smaller-c-NAS/share-news/North-Atlantic-Smlr-Co-Inv-Tst-PLC-Final-Results/82437593 htTps://www.nascit.co.uk
rambutan2
29/4/2020
21:47
It’s one of my larger holdings. Mills bought £3m of shares at £30 when he knew roughly what NAV looked like. I suspect current NAV isn’t far off the £40 that HL shows so trading at a 30%+ discount which in these mkts given its structure and manager with a lot of skin in game is too much. I think it should be trading north of £30 but for me I’m happy to follow Mills.
andycapp1
29/4/2020
14:22
Morning Star have estimated NAV at 4,022. Discount -31.89%
killing_time
Chat Pages: 11  10  9  8  7  6  5  4  3  2  1
ADVFN Advertorial
Your Recent History
LSE
NAS
North Atla..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201022 16:24:29